Ortho Clinical Diagnostics Reagent Kit Vitros® Antibody Test Anti-SARS-CoV-2 IgG For use with Vitro ECi / ECiQ (Available End of May) / Vitros 3600 / 5600 / XT7600 100 Tests - Each - 6199919-EA

Ortho Clinical Diagnostics Reagent Kit Vitros® Antibody Test Anti-SARS-CoV-2 IgG For use with Vitro ECi / ECiQ (Available End of May) / Vitros 3600 / 5600 / XT7600 100 Tests - Each - 6199919-EA

Regular price $4,039.99
Sale price $4,039.99 Regular price
OFF Sold out
Shipping calculated at checkout.

50 In stock

Estimated deliver:

Flat-Rate Shipping from $8.25

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Reviews

Ortho Clinical Diagnostics Reagent Kit Vitros® Antibody Test Anti-SARS-CoV-2 IgG For use with Vit...

Item Id 1166249
MF Id# 6199919
Brand Vitros®
Manufacturer Ortho Clinical Diagnostics
Country of Origin United Kingdom
Application Reagent Kit
Container Type Well
For Use With For use with Vitro ECi / ECiQ (Available End of May) / Vitros 3600 / 5600 / XT7600
Form Liquid
Number of Tests 100 Tests
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Sample Type Human Serum
Storage Requirements Requires Refrigeration
Test Method Chemiluminescent Immunoassay
Test Name Anti-SARS-CoV-2 IgG
Test Type Antibody Test
Time to Results 48 Minute Results
UNSPSC Code 41116020

Features

  • VITROS Anti-SARS-CoV-2 IgG test is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. section 263a, to perform moderate and high complexity tests
  • Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities
  • The sensitivity of VITROS Anti-SARS-CoV-2 IgG test in early infection is unknown; negative results do not preclude acute SARS-CoV-2 infection - if acute infection is suspected, direct testing for SARS-CoV-2 is necessary
  • False positive results for VITROS Anti-SARS-CoV-2 IgG test may occur due to cross-reactivity from pre-existing antibodies or other possible causes
  • VITROS Anti-SARS-CoV-2 IgG test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection
  • At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity
  • VITROS Anti-SARS-CoV-2 IgG test should not be used to diagnose acute SARS-CoV-2 infection
  • VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack when used in combination with the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Calibrator is a chemiluminescent immunoassay test intended for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum
  • Reagent Pack contains: 100 coated wells (recombinant SARS-CoV-2 antigen derived from human cells, coated at 110 ng/well), 18.0 mL assay reagent (buffer with bovine protein stabilizers and antimicrobial agent), 20.4 mL conjugate reagent [anti-human IgG (murine monoclonal) conjugated to horseradish peroxidase, 5 ng/mL] in buffer with bovine protein stabilizers and antimicrobial agent
  • Rx ONLY, For in vitro diagnostic and Laboratory Professional use; For Emergency Authorization Use ONLY

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
About your query!
Recently Viewed